PSEUDOHYPOPARATHYROIDISM
Clinical trials for PSEUDOHYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new PSEUDOHYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for PSEUDOHYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Asthma drug shows promise for rare genetic disorder
Disease control OngoingThis study tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism lose weight and improve blood sugar control. The trial involves 29 obese teenagers and young adults aged 13 and older. Researchers will measure changes in body mass index …
Matched conditions: PSEUDOHYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Old asthma drug shows promise for rare genetic disorder
Disease control ENROLLING_BY_INVITATIONThis study tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism, a rare genetic condition causing early obesity, short stature, and hormone problems. About 34 children and young adults who completed a prior trial will take the drug to …
Matched conditions: PSEUDOHYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: Jaclyn Tamaroff • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Old asthma drug may help kids with rare genetic disorder
Disease control OngoingThis study is testing whether theophylline, a medication long used for asthma, can help children with a rare genetic disorder called pseudohypoparathyroidism. Researchers want to see if the drug helps with weight loss, slows bone maturation to allow for more growth, and reduces t…
Matched conditions: PSEUDOHYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC